| Jun 26 |
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
|
| Jun 11 |
Tiziana multiple sclerosis asset foralumab Fast Track application accepted
|
| Jun 11 |
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
|
| Jun 6 |
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
|
| Jun 4 |
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
|
| May 30 |
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
|
